Showing results (231-240 of 236) with videos related to
Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 236 results.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|August 8, 2001
[Immunomodulating treatment in advanced heart failure--effect of intravenous immunoglobulin]L Gullestad, H Aass, A K Andreassen, et al.Clinical Pharmacology and Therapeutics|November 7, 2013
An investigation of CYP2D6 genotype and response to metoprolol CR/XL during dose titration in patients with heart failure: a MERIT-HF substudyJ A Batty, A S Hall, H L White, et al.Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
CXC-chemokines in coronary artery disease: possible pathogenic role of interactions between oxidized low-density lipoprotein, platelets and peripheral blood mononuclear cellsT Holm, J K Damås, K Holven, et al.Journal of the American College of Cardiology|June 7, 2000
Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systematic overview of individual data from 96,712 randomized patients. Angiotensin-converting Enzyme Inhibitor Myocardial Infarction Collaborative GroupR Latini, G Tognoni, A P Maggioni, et al.JAMA|March 14, 2000
Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study GroupA Hjalmarson, S Goldstein, B Fagerberg, et al.Journal of Internal Medicine|February 16, 2006
Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panelP J Barter, C M Ballantyne, R Carmena, et al.Pageof 24